Correlation Between Inozyme Pharma and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Dermata Therapeutics, you can compare the effects of market volatilities on Inozyme Pharma and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Dermata Therapeutics.
Diversification Opportunities for Inozyme Pharma and Dermata Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Dermata is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Dermata Therapeutics
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Dermata Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Inozyme Pharma is 1.34 times less risky than Dermata Therapeutics. The stock trades about -0.83 of its potential returns per unit of risk. The Dermata Therapeutics is currently generating about -0.29 of returns per unit of risk over similar time horizon. If you would invest 157.00 in Dermata Therapeutics on August 23, 2024 and sell it today you would lose (42.00) from holding Dermata Therapeutics or give up 26.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Dermata Therapeutics
Performance |
| Timeline |
| Inozyme Pharma |
| Dermata Therapeutics |
Inozyme Pharma and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Dermata Therapeutics
The main advantage of trading using opposite Inozyme Pharma and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| Inozyme Pharma vs. ZyVersa Therapeutics | Inozyme Pharma vs. Sonnet Biotherapeutics Holdings | Inozyme Pharma vs. Zura Bio Limited | Inozyme Pharma vs. Phio Pharmaceuticals Corp |
| Dermata Therapeutics vs. ZyVersa Therapeutics | Dermata Therapeutics vs. Sonnet Biotherapeutics Holdings | Dermata Therapeutics vs. Zura Bio Limited | Dermata Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |